888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
OV803cOvary cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV803b
Cores80Cases80
Row number8Column number10
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:OV803c
 
Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV803b
 
Price: $185.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IIIC)
 
Malignant (IV)
TISSUE  ARRAYS OV803c
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1142FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A2222FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignant
A3359FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A4448FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A5538FOvarySerous papillary adenocarcinoma1T3cN1M0IIICMalignant
A6647FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A7725FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A8851FOvarySerous papillary adenocarcinoma1T3cN1M0IIICMalignant
A9926FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
A101044FOvarySerous papillary adenocarcinoma2T3N0M0IIIMalignant
B11152FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
B21234FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
B31350FOvarySerous papillary adenocarcinoma2T1N0M0IMalignant
B41453FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
B51551FOvarySerous papillary adenocarcinoma3T3N1M0IIICMalignant
B61650FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignant
B71764FOvarySerous papillary adenocarcinoma with necrosis3T3N1M0IIICMalignant
B81860FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
B91935FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
B102053FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
C12149FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
C22253FOvarySerous papillary adenocarcinoma2T2N0M1IVMalignant
C32351FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
C42454FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
C52573FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignant
C62668FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
C72751FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
C82852FOvarySerous papillary adenocarcinoma2--3T2N0M0IIMalignant
C92951FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
C103048FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
D13155FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
D23254FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
D33360FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
D43447FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
D53558FOvarySerous adenocarcinoma3T1N0M0IMalignant
D63657FOvarySerous papillary adenocarcinoma2T1cN0M0ICMalignant
D73745FOvarySerous papillary adenocarcinoma2T1N0M0IMalignant
D83838FOvarySerous papillary adenocarcinoma2--3T3bN1M0IIICMalignant
D93956FOvarySerous papillary adenocarcinoma2--3T2N0M0IIMalignant
D104055FOvarySerous papillary adenocarcinoma2--3T1N0M0IMalignant
E14141FOvarySerous papillary adenocarcinoma2T1N0M0IMalignant
E24250FOvarySerous adenocarcinoma3T1N0M0IMalignant
E34349FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
E44446FOvarySerous papillary adenocarcinoma2T3aN1M0IIICMalignant
E54548FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
E64646FOvarySerous adenocarcinoma with necrosis3T2cN1M0IIICMalignant
E74752FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
E84852FOvarySerous adenocarcinoma3T2N0M0IIMalignant
E94957FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
E105054FOvarySerous adenocarcinoma3T1bN0M0IBMalignant
F15166FOvarySerous papillary adenocarcinoma3T3N1M0IIICMalignant
F25249FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
F35354FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
F45442FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignant
F55560FOvarySerous adenocarcinoma3T1aN0M0IAMalignant
F65647FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
F75756FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignant
F85847FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
F95959FOvarySerous papillary adenocarcinoma3T2bN0M0IIBMalignant
F106041FOvarySerous adenocarcinoma3T3N0M0IIIMalignant
G16149FOvarySerous adenocarcinoma3T2N0M0IIMalignant
G26254FOvarySerous papillary adenocarcinoma3T2bN0M0IIBMalignant
G36360FOvarySerous adenocarcinoma3T1bN0M0IBMalignant
G46439FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
G56534FOvaryMucinous papillary adenocarcinoma1T1N0M0IMalignant
G66640FOvaryMucinous papillary adenocarcinoma1T1aN0M0IAMalignant
G76739FOvaryMucinous papillary adenocarcinoma1T2N0M0IIMalignant
G86854FOvaryMucinous papillary adenocarcinoma2T2aN0M0IIAMalignant
G96965FOvaryMucinous papillary adenocarcinoma2T2aN0M0IIAMalignant
G107033FOvaryMucinous papillary adenocarcinoma2T1N0M0IMalignant
H17145FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant
H27241FOvaryMucinous adenocarcinoma2--3T1bN0M0IBMalignant
H37337FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignant
H47429FOvaryMucinous adenocarcinoma3T3N0M0IIIMalignant
H57559FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
H67652FOvaryMucinous adenocarcinoma3T1bN0M0IBMalignant
H77749FOvaryEndometrioid adenocarcinoma1--2T1N0M0IMalignant
H87855FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignant
H97961FOvaryEndometrioid adenocarcinoma3T3N0M0IIIMalignant
H108050FOvaryClear cell carcinoma*T1N0M0IMalignant
Tissue Marker
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs